Dr. Vikas Majithia with a patient with rheumatoid arthritis.

Patients & Families

 

Patients and families can find hope and make an impact on the search for a cure.

 

Learn about current research aiming to improve the lives of these patients living with rheumatic disease with funding from the Rheumatology Research Foundation.

 

Jarred Younger - 320 x 215

Jarred Younger, PhD
University of Alabama at Birmingham

Approximately half of individuals with rheumatoid arthritis experience profound fatigue and pain, even after their joint disease activity has been improved by medications. The symptoms suggest that the inflammation caused by rheumatoid arthritis might also impact the brain and nervous system. Jarred W. Younger, PhD,  associate professor at the University of Alabama at Birmingham, is studying brain thermometry, a noninvasive method that could detect and measure the neuroinflammation caused by rheumatoid arthritis. His technique could help doctors better understand the cause of the pain and fatigue experienced daily by people like Elizabeth.

University of North Carolina Rheumatologist Dr. Teresa Tarrant.

Teresa Tarrant, MD

Dr. Tarrant is studying a new technology that could deliver rheumatoid arthritis medication straight to the affected joints.

Link

Dr. Gary Firestein

Gary S. Firestein, MD

Dr. Firestein is studying the LBH gene to better understand the genetic mechanisms behind joint damage and synovial inflammation.

Link

Veronique LefebVre, PhD

Dr. Lefebvre is using stem cells to better understand joint damage caused by rheumatoid arthritis.

Link

A young femaie holds the inflamed hands of a man with rheumatoid arthritis.

Foundation Voice

Get the latest news and updates on Foundation-funded research and training.

Click Thru

Link

Volunteer

We need your expertise and passion to make a difference in the search for a cure.

Click Thru

Link

Join the Conversation

Help raise awareness and support others. Share your story on our Facebook page.

Click Thru

Link

Give today and help transform the future for millions of people living with rheumatic disease.